RQx lands funding through hard work and luck

11/29/2012 | Xconomy

RQx Pharmaceuticals was born after researcher Floyd Romesberg and investor Court Turner happened to strike up a conversation in a local coffee shop. Romesberg is developing arylomycin to work against gram-negative and -positive bacteria, potentially leading to a new broad-spectrum antibiotic. Turner's company, Avalon Ventures, provided the first $1 million for Romesberg to start a new company, and Correlation Ventures has since joined as a venture investor.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health